Advisor HD Grid Observational Study

  • Research type

    Research Study

  • Full title

    Advisor HD Grid Observational Study

  • IRAS ID

    257826

  • Contact name

    Pier Lambiase

  • Contact email

    p.lambiase@ucl.ac.uk

  • Sponsor organisation

    Abbott Medical UK

  • Clinicaltrials.gov Identifier

    NCT03733392

  • Duration of Study in the UK

    2 years, 9 months, 15 days

  • Research summary

    Heart rhythm problems (heart arrhythmias) occur when the electrical impulses that coordinate your heartbeats don't work properly, causing your heart to beat too fast, too slow or irregularly. Heart arrhythmias may feel like a fluttering or racing heart and may be harmless. However, some heart arrhythmias may cause bothersome — sometimes even life-threatening — signs and symptoms. Catheter ablation is used to treat many types of arrhythmias, such as Atrial fibrillation (an irregular and often rapid heartbeat that begins in the upper chambers of the heart) and Ventricular tachycardia (a rapid heartbeat that begins in the lower chambers of the heart). The ablation procedure requires the use of a diagnostic mapping catheter, which maps the heart to ensure effective ablation treatment is given by the doctor during the procedure. The doctor will create heart maps and treat the patient’s heart rhythm disorder as per normal standard practice in hospital. The study aims to evaluate whether the use of Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ (HD grid) will enable better view of the area of the heart requiring ablation treatment. The purpose of this clinical study is to evaluate the clinical use of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ (HD grid) during ablation procedures, and the effectiveness of this ablation procedure to treat heart rhythm disorders in real-world clinical settings (via this observational study). Patients will be followed up in addition to their normal standard care. Follow ups will occur pre-discharge, 6-months and 12-months. Information will be collected during this study and will include data about the patient’s overall heart condition, the catheter mapping and ablation procedure, and how the patient is following the procedure. Patients will be asked to complete questionnaires which include how they are physically and emotionally feeling.

  • REC name

    London - West London & GTAC Research Ethics Committee

  • REC reference

    19/LO/0979

  • Date of REC Opinion

    28 Jun 2019

  • REC opinion

    Unfavourable Opinion